Publications by authors named "Vamsidhar Velcheti"

93Publications

MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?

Curr Genomics 2020 Aug;21(5):372-381

1Departamento de Biomedicina da Faculdade de Medicina, and Faculdade de Ciências da Nutrição e Alimentação, and I3s, Universidade do Porto, Porto, Portugal; 2Algarve Biomedical Centre, Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal; 3Department of Clinical & Experimental Oncology, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil; 4Precision Oncology and Health Economic Group, Nine of July University, São Paulo, Brazil; 5Department of Digestive Surgery, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; 6Department of Oncology, Albert Einstein Israelite Hospital, São Paulo, Brazil; 7Thoracic Oncology Program, NYU Langone, Perlmutter Cancer Center, New York, NY, 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389202921999200630144712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536806PMC
August 2020

Efficacy of Selpercatinib in Fusion-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2020 08;383(9):813-824

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (A.D., E.R.) and New York University Langone Medical Center (V.V.), New York, and Roswell Park Comprehensive Cancer Center, Buffalo (G.K.D.) - all in New York; Dana-Farber Cancer Institute (G.R.O.) and Massachusetts General Hospital (J.G.), Boston; National Cancer Centre Singapore, Singapore (D.S.W.T.); the Chinese University of Hong Kong, Hong Kong, China (H.H.F.L.); Sarah Cannon Research Institute, Nashville (M.J.); University of California, San Francisco-Helen Diller Family Comprehensive Cancer Center, San Francisco (C.E.M.), University of California, San Diego, Moores Cancer Center, La Jolla (L.B.), and City of Hope Comprehensive Cancer Center, Duarte (K.L.R.) - all in California; University of Bern, Bern, and Cantonal Hospital of Lucerne, Lucerne - both in Switzerland (O.G.); Institut Gustave Roussy, Villejuif (B.B.), Hospital La Timone, Marseille (F.B.), and Centre Léon Bérard, Lyon (P.A.C.) - all in France; Severance Hospital, Yonsei University Health System (B.C.C.), and Samsung Medical Center, Sungkyunkwan University School of Medicine (K.P.), Seoul, and Seoul National University Bundang Hospital, Seongnam (Y.J.K.) - all in South Korea; Soroka University Medical Center, Beer-Sheva, Israel (N.P.); University of North Carolina-Chapel Hill, Chapel Hill (J. Weiss); National Cancer Center Hospital (Y.O.) and Cancer Institute Hospital of the Japanese Foundation for Cancer Research (M. Nishio), Tokyo, National Hospital Organization Kyushu Cancer Center, Fukuoka (T. Seto), Tottori University Hospital, Tottori (T. Sakamoto), Hyogo Cancer Center, Akashi (M.S.), Okayama University Hospital, Okayama (K.O.), and National Cancer Center Hospital East, Chiba (K.G.) - all in Japan; University of Chicago, Chicago (J.P.); the Ohio State University Comprehensive Cancer Center, Columbus (M.H.S.), and Cleveland Clinic, Cleveland (N.A.P.); Istituto Nazionale Tumori-National Cancer Institute, Università degli Studi di Milano, Milan (F.D.B.); Vall d'Hebron Institute of Oncology, Hospital Universitario Vall d'Hebron, Barcelona (E.G.); Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany (J. Wolf); Peter MacCallum Cancer Institute, Melbourne, VIC, Australia (B.S.); Sarah Cannon Research Institute at HealthONE, Denver (G.F.); Loxo Oncology, Stamford, CT (K.E., M. Nguyen, B.N., E.Y.Z., L.Y., X.H., E.O., S.M.R.); and the University of Texas M.D. Anderson Cancer Center, Houston (V.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa2005653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506467PMC
August 2020

Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival.

Clin Lung Cancer 2020 Sep 8;21(5):e445-e455. Epub 2020 Mar 8.

Merck & Co, Inc, Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.02.023DOI Listing
September 2020

State-of-the-Art Strategies for Targeting -Dependent Cancers.

J Clin Oncol 2020 Apr 21;38(11):1209-1221. Epub 2020 Feb 21.

Department of Investigational Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145587PMC
April 2020

Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma.

Radiol Artif Intell 2019 Mar 20;1(2):e180012. Epub 2019 Mar 20.

Department of Biomedical Engineering, Case Western Reserve University School of Engineering, 2071 Martin Luther King Dr, Cleveland, OH 44106-7207 (M. Khorrami, K.B., A.M.); Departments of Internal Medicine (M. Khunger) and Solid Tumor Oncology (A.Z., P.P.), Cleveland Clinic, Cleveland, Ohio; Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY (R.T.); Department of Radiology, UT Southwestern Medical Center, Dallas, Tex (P.R.); Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio (P.F.); Department of Hematology and Oncology, New York University, New York, NY (V.V.); Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, Ohio (A.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/ryai.2019180012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515986PMC
March 2019

Outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic NSCLC at US oncology practices.

Immunotherapy 2019 12 27;11(18):1541-1554. Epub 2019 Nov 27.

Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0177DOI Listing
December 2019

Corrigendum to "Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features" [Lung Cancer 135 (September) (2019) 1-9].

Lung Cancer 2019 Oct 21;136:156. Epub 2019 Aug 21.

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Louis Stokes Cleveland Veterans Administration Medical Center, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.012DOI Listing
October 2019

Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.

Lung Cancer 2019 09 5;135:1-9. Epub 2019 Jul 5.

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Louis Stokes Cleveland Veterans Administration Medical Center, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.06.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711393PMC
September 2019

Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.

Nat Rev Clin Oncol 2019 11 9;16(11):703-715. Epub 2019 Aug 9.

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0252-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880861PMC
November 2019

First-line pembrolizumab monotherapy for metastatic PD-L1-positive NSCLC: real-world analysis of time on treatment.

Immunotherapy 2019 07 11;11(10):889-901. Epub 2019 Jun 11.

Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0061DOI Listing
July 2019

EZH2 Inhibitors: Take It EZy, It Is All About Context.

Cancer Discov 2019 Apr;9(4):472-475

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-0090DOI Listing
April 2019

Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas.

Radiology 2019 03 18;290(3):783-792. Epub 2018 Dec 18.

From the Department of Biomedical Engineering, Case Western Reserve University, 2071 Martin Luther King Dr, Wickenden 523, Cleveland, OH 44106-7207 (N. Beig, M.K., M.A., P.P., N. Braman, M.O., K.B., P.T., A.M.); Taussig Cancer Institute-Cleveland Clinic, Cleveland, Ohio (S.R.); Division of Thoracic and Esophageal Surgery (J.G., P.L.), Division of Pulmonary Critical Care and Sleep Medicine (C.D., F.J.), Department of Pathology (M.Y.), and Department of Radiology (R.G.), University Hospitals of Cleveland, Cleveland, Ohio; Pulmonary Section, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio (F.J.); Department of Radiology, UT Southwestern Medical Center, Dallas, Tex (P.R.); Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY (R.T.); and Hematology and Oncology, New York University, Perlmutter Cancer Center, New York, NY (V.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018180910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394783PMC
March 2019

Response.

Chest 2018 10;154(4):993-994

Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2018.07.031DOI Listing
October 2018

Ultimate Precision: Targeting Cancer but Not Normal Self-replication.

Am Soc Clin Oncol Educ Book 2018 May;38:950-963

From the Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Thoracic Oncology, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_199753DOI Listing
May 2018

Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications.

Am Soc Clin Oncol Educ Book 2018 May;38:1008-1018

From the Case Western Reserve University, Cleveland, OH; Cleveland Clinic Foundation, Cleveland, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/EDBK_199747
Publisher Site
http://dx.doi.org/10.1200/EDBK_199747DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152883PMC
May 2018

WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.

J Thorac Oncol 2018 07;13(7):e122-e123

Foundation Medical, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.003DOI Listing
July 2018

in Lung Cancers: Analysis of Patient Cases Reveals Recurrent Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.

JCO Precis Oncol 2018 19;2. Epub 2018 Apr 19.

, Vancouver General Hospital, Vancouver, British Columbia, Canada; , , , , , , , , , , , , , , , , , , and , Foundation Medicine, Cambridge, MA; , The Angeles Clinic and Research Institute and Cedars-Sinai Medical Center, Los Angeles; , University of California San Diego, San Diego; , University of California, San Francisco, San Francisco; and , University of California, Irvine, Medical Center, Irvine, CA; , Cleveland Clinic; and , University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH; , Soroka Medical Center and Ben-Gurion University, Beer-Sheve, Israel; , Northwestern University Feinberg School of Medicine Northwestern Medical Center, Chicago, IL; and , Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446447PMC
April 2018

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience.

Ther Adv Respir Dis 2018 Jan-Dec;12:1753466618767611

Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753466618767611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941661PMC
January 2019

Biomarkers for immune-related toxicities of checkpoint inhibitors: current progress and the road ahead.

Expert Rev Mol Diagn 2018 03 15;18(3):297-305. Epub 2018 Feb 15.

a Department of Hematology and Oncology , Taussig Cancer Institute, Cleveland Clinic , Cleveland , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2018.1440209DOI Listing
March 2018

Role of immune-checkpoint inhibitors in lung cancer.

Ther Adv Respir Dis 2018 Jan-Dec;12:1753465817750075

Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753465817750075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937156PMC
January 2019

Radiomics and radiogenomics in lung cancer: A review for the clinician.

Lung Cancer 2018 01 8;115:34-41. Epub 2017 Nov 8.

Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.10.015DOI Listing
January 2018

Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer.

Oncotarget 2017 Sep 28;8(43):73745-73756. Epub 2017 Aug 28.

Division of Hematology and Oncology, Case Western Reserve University, University Hospitals Seidman Cancer Center, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650296PMC
September 2017

Non-invasive diagnostic platforms in management of non-small cell lung cancer: opportunities and challenges.

Ann Transl Med 2017 Sep;5(18):378

Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2017.08.24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635261PMC
September 2017

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer.

J Immunother Cancer 2017 10 17;5(1):81. Epub 2017 Oct 17.

Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0285-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644103PMC
October 2017

To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis.

J Thorac Oncol 2017 09;12(9):e147-e149

Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.05.005DOI Listing
September 2017

Challenges faced when identifying patients for combination immunotherapy.

Future Oncol 2017 Aug 24;13(18):1607-1618. Epub 2017 Aug 24.

Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0218DOI Listing
August 2017

A case of crizotinib-induced esophageal ulcers.

Lung Cancer Manag 2017 Jul 14;6(1):5-7. Epub 2017 Jul 14.

Cleveland Clinic Foundation, 9500 Euclid ave, Cleveland, OH 44195, OH, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/lmt-2016-0017
Publisher Site
http://dx.doi.org/10.2217/lmt-2016-0017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310301PMC
July 2017

Intracranial and Systemic Response to Alectinib in a Patient with RET-KIF5B Oncogenic Fusion.

J Thorac Oncol 2017 07;12(7):e98-e99

Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.03.007DOI Listing
July 2017

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab.

J Thorac Oncol 2017 07;12(7):e96-e97

Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128997PMC
July 2017

Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer.

Am Soc Clin Oncol Educ Book 2017 ;37:812-824

From the Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH; Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_174175DOI Listing
November 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Novel EGFR Exon 18 (G721R) Mutation in a Patient with Non-Small Cell Lung Carcinoma with Lack of Response to Afatinib.

J Thorac Oncol 2017 02;12(2):e16-e18

Department of Translational Hematology Oncology Research Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.11.273DOI Listing
February 2017

Durable Response to Combination of Dabrafenib and Trametinib in BRAF V600E-Mutated Non-small-cell Lung Cancer.

Clin Lung Cancer 2017 05 11;18(3):e211-e213. Epub 2016 Nov 11.

Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.11.001DOI Listing
May 2017

Breast Mass in a Woman with Recurrent Thymoma.

Ann Am Thorac Soc 2016 11;13(11):2097-2098

1 Cleveland Clinic R. J. Tomsich Pathology and Laboratory Medicine Institute Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.201606-480LEDOI Listing
November 2016

Focal lung infiltrate complicating PD-1 inhibitor use: A new pattern of drug-associated lung toxicity?

Respir Med Case Rep 2016 8;19:118-20. Epub 2016 Sep 8.

Education Institute, Respiratory Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmcr.2016.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026692PMC
September 2016

Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases.

Ann Rheum Dis 2017 01 26;76(1):1-3. Epub 2016 Aug 26.

Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209782DOI Listing
January 2017

Adjuvant Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer: Yes, No, Maybe So?

Chest 2016 06;149(6):1357-9

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.01.032DOI Listing
June 2016

Basic Overview of Current Immunotherapy Approaches in Cancer.

Am Soc Clin Oncol Educ Book 2016 ;35:298-308

From the Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Departments of Pathology and Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_156572DOI Listing
January 2017

Coexistent pulmonary granular cell tumor and adenocarcinoma of the lung.

Transl Lung Cancer Res 2014 Aug;3(4):262-4

1 Department of Internal Medicine, 2 Department of Anatomic Pathology, 3 Department of Surgery, 4 Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.06.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367698PMC
August 2014

Objective measurement and clinical significance of TILs in non-small cell lung cancer.

J Natl Cancer Inst 2015 Mar 3;107(3). Epub 2015 Feb 3.

Department of Pathology (KAS, JB, DCH, DLR) and Medical Oncology (JM, RSH), Yale University School of Medicine, New Haven, CT; Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH (VV); Oncology Unit, 3rd Department of Medicine, School of Medicine, University of Athens, Sotiria General Hospital, Athens, Greece (KNS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565530PMC
March 2015

RET-rearranged lung adenocarcinomas with lymphangitic spread, psammoma bodies, and clinical responses to cabozantinib.

J Thorac Oncol 2014 Nov;9(11):1714-9

*Departments of Pathology, †Solid Tumor Oncology, and ‖Translational Hematology and Oncology Research, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH; ‡Foundation Medicine, Cambridge, MA; and §Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000323DOI Listing
November 2014

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.

Clin Cancer Res 2014 May 19;20(10):2773-82. Epub 2014 Mar 19.

Authors' Affiliations: Departments of Pathology and Medical Oncology, Yale School of Medicine, New Haven, Connecticut; and Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2702DOI Listing
May 2014

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).

J Thorac Oncol 2013 Jun;8(6):803-5

Department of Medical Oncology and Pathology, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318292be18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703468PMC
June 2013

Management of patients with advanced non-small cell lung cancer: role of gefitinib.

Biologics 2010 May 25;4:83-90. Epub 2010 May 25.

Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880342PMC
http://dx.doi.org/10.2147/btt.s4144DOI Listing
May 2010

Radiation-induced myonecrosis presenting as a subcutaneous mass after combined modality therapy for non-small cell lung cancer.

J Thorac Oncol 2007 Sep;2(9):875-6

Division of Oncology, Alvin J. Siteman Cancer Center Washington University School of Medicine, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31811f3a91DOI Listing
September 2007

Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).

J Thorac Oncol 2007 Sep;2(9):827-30

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641530871
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e318145af79DOI Listing
September 2007

Hedgehog signaling is a potent regulator of angiogenesis in small cell lung cancer.

Med Hypotheses 2007 16;69(4):948-9. Epub 2007 Jul 16.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mehy.2007.02.021DOI Listing
October 2007

Hedgehog signaling pathway and lung cancer.

J Thorac Oncol 2007 Jan;2(1):7-10

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31802c0276DOI Listing
January 2007

Insulin-like growth factor and lung cancer.

J Thorac Oncol 2006 Sep;1(7):607-10

Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
September 2006

Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen.

Lung Cancer 2007 Aug 2;57(2):240-2. Epub 2007 Apr 2.

Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.02.010DOI Listing
August 2007

Metastatic cancer involving bladder: a review.

Can J Urol 2007 Feb;14(1):3443-8

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
February 2007